Literature DB >> 16924140

Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides.

Iwao Isomura1, Akimichi Morita.   

Abstract

The nuclear factor-kappa B (NF-kappaB) plays a critical role in regulating expression of genes responsible for a wide range of cellular processes, including innate and adoptive immune responses, and pathways related to cell survival and proliferation. Based on its property as a transcription factor, NF-kappaB has been considered as a good target for the treatment of inflammatory immune diseases. To regulate gene expression, "decoy" oligodeoxynucleotides (ODNs) are ideal tools to interfere with binding of transcription factors to promoter regions in genes. Herein we review the application of NF-kappaB decoy ODNs to control inflammatory disorders and transplantation tolerance. In addition, we provide information about induction of antigen-specific peripheral tolerance by their topical application. Regulation of NF-kappaB signaling by NF-kappaB decoy ODNs might be an effective tool to control a variety of disorders caused by inflammatory immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924140     DOI: 10.1111/j.1348-0421.2006.tb03827.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  8 in total

Review 1.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

2.  Photochemical control of DNA decoy function enables precise regulation of nuclear factor κB activity.

Authors:  Jeane M Govan; Mark O Lively; Alexander Deiters
Journal:  J Am Chem Soc       Date:  2011-07-29       Impact factor: 15.419

3.  Suppressive Effect on Lipopolysaccharide-Induced Proinflammatory Mediators by Citrus aurantium L. in Macrophage RAW 264.7 Cells via NF-κB Signal Pathway.

Authors:  Sang-Rim Kang; Dae-Yong Han; Kwang-Il Park; Hyeon-Soo Park; Yong-Bae Cho; Hu-Jang Lee; Won-Sup Lee; Chung Ho Ryu; Yeong Lae Ha; Do Hoon Lee; Jin A Kim; Gon-Sup Kim
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-21       Impact factor: 2.629

4.  Regulation of Proinflammatory Mediators via NF-κB and p38 MAPK-Dependent Mechanisms in RAW 264.7 Macrophages by Polyphenol Components Isolated from Korea Lonicera japonica THUNB.

Authors:  Kwang-Il Park; Sang-Rim Kang; Hyeon-Soo Park; Do Hoon Lee; Arulkumar Nagappan; Jin A Kim; Sung Chul Shin; Eun Hee Kim; Won Sup Lee; Hyon-Jong Chung; Su Jin An; Gon Sup Kim
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-07       Impact factor: 2.629

Review 5.  Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression.

Authors:  Yu Rou Puar; Muthu K Shanmugam; Lu Fan; Frank Arfuso; Gautam Sethi; Vinay Tergaonkar
Journal:  Biomedicines       Date:  2018-07-27

Review 6.  Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer.

Authors:  Sander W Tas; Margriet J B M Vervoordeldonk; Paul P Tak
Journal:  Curr Gene Ther       Date:  2009-06       Impact factor: 4.391

7.  Activation of nuclear factor-κB in the brain after experimental subarachnoid hemorrhage and its potential role in delayed brain injury.

Authors:  Wan-Chun You; Chun-Xi Wang; Yun-Xi Pan; Xin Zhang; Xiao-Ming Zhou; Xiang-Sheng Zhang; Ji-Xin Shi; Meng-Liang Zhou
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

8.  Induction of endogenous gamma-globin gene expression with decoy oligonucleotide targeting Oct-1 transcription factor consensus sequence.

Authors:  Xiaoxin S Xu; Xin Hong; Gan Wang
Journal:  J Hematol Oncol       Date:  2009-03-27       Impact factor: 17.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.